Rotavirus infections and their genotype distribution pre- and post-vaccine introduction in Ethiopia: a systemic review and meta-analysis
Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in high deaths annually, mainly in low-income countries,...
Saved in:
| Published in | BMC infectious diseases Vol. 24; no. 1; pp. 836 - 13 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
16.08.2024
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in high deaths annually, mainly in low-income countries, including Ethiopia, and need special attention. This system review and meta-analysis aimed to comprehensively explore the positive proportion of rotavirus at pre- and post-vaccine introduction periods and genotype distribution in children under five with diarrhea in Ethiopia.
The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Database sources included PubMed, Scopus, EMBASE, and Epistemonikos, focusing on studies published before November 30, 2023. The search targeted rotavirus infection and genotype distribution in Ethiopia before and after the introduction of the Rota vaccine. Data was managed using EndNote 2020 software and stored in an Excel 2010 sheet. A random-effects model determined the pooled estimate of the rotavirus infection rate at 95% confidence intervals. The Q-and I² statistics were used to assess the study heterogeneity, and a funnel plot (Egger test) was used to determine the possibility of publication bias.
The analysis included data from nine studies conducted in different regions of Ethiopia. The overall prevalence of rotavirus infection was significant, with a prevalence rate of approximately 22.63% (1362/6039). The most common genotypes identified before the Rota vacation introduction were G1, G2, G3, G12, P [4], P [6], P [8], P [9], and P [10]. Meanwhile, G3 and P [8] genotypes were particularly prevalent after the Rota vaccine introduction. These findings highlight the importance of implementing preventive measures, such as vaccination, to reduce the burden of rotavirus infection in this population. The identified genotypes provide valuable insights for vaccine development and targeted interventions.
This study contributes to the evidence base for public health interventions and strategies to reduce the impact of rotavirus infection in children under five in Ethiopia. Despite the rollout of the Rota vaccination in Ethiopia, rotavirus heterogeneity is still high, and thus, enhancing vaccination and immunization is essential. |
|---|---|
| AbstractList | Background Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in high deaths annually, mainly in low-income countries, including Ethiopia, and need special attention. This system review and meta-analysis aimed to comprehensively explore the positive proportion of rotavirus at pre- and post-vaccine introduction periods and genotype distribution in children under five with diarrhea in Ethiopia. Methods The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Database sources included PubMed, Scopus, EMBASE, and Epistemonikos, focusing on studies published before November 30, 2023. The search targeted rotavirus infection and genotype distribution in Ethiopia before and after the introduction of the Rota vaccine. Data was managed using EndNote 2020 software and stored in an Excel 2010 sheet. A random-effects model determined the pooled estimate of the rotavirus infection rate at 95% confidence intervals. The Q-and I² statistics were used to assess the study heterogeneity, and a funnel plot (Egger test) was used to determine the possibility of publication bias. Results The analysis included data from nine studies conducted in different regions of Ethiopia. The overall prevalence of rotavirus infection was significant, with a prevalence rate of approximately 22.63% (1362/6039). The most common genotypes identified before the Rota vacation introduction were G1, G2, G3, G12, P [4], P [6], P [8], P [9], and P [10]. Meanwhile, G3 and P [8] genotypes were particularly prevalent after the Rota vaccine introduction. These findings highlight the importance of implementing preventive measures, such as vaccination, to reduce the burden of rotavirus infection in this population. The identified genotypes provide valuable insights for vaccine development and targeted interventions. Conclusion This study contributes to the evidence base for public health interventions and strategies to reduce the impact of rotavirus infection in children under five in Ethiopia. Despite the rollout of the Rota vaccination in Ethiopia, rotavirus heterogeneity is still high, and thus, enhancing vaccination and immunization is essential. Keywords: Rotavirus infection, Genotypes, Pre-vaccine, Post-vaccine, Ethiopia Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in high deaths annually, mainly in low-income countries, including Ethiopia, and need special attention. This system review and meta-analysis aimed to comprehensively explore the positive proportion of rotavirus at pre- and post-vaccine introduction periods and genotype distribution in children under five with diarrhea in Ethiopia. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Database sources included PubMed, Scopus, EMBASE, and Epistemonikos, focusing on studies published before November 30, 2023. The search targeted rotavirus infection and genotype distribution in Ethiopia before and after the introduction of the Rota vaccine. Data was managed using EndNote 2020 software and stored in an Excel 2010 sheet. A random-effects model determined the pooled estimate of the rotavirus infection rate at 95% confidence intervals. The Q-and I² statistics were used to assess the study heterogeneity, and a funnel plot (Egger test) was used to determine the possibility of publication bias. The analysis included data from nine studies conducted in different regions of Ethiopia. The overall prevalence of rotavirus infection was significant, with a prevalence rate of approximately 22.63% (1362/6039). The most common genotypes identified before the Rota vacation introduction were G1, G2, G3, G12, P [4], P [6], P [8], P [9], and P [10]. Meanwhile, G3 and P [8] genotypes were particularly prevalent after the Rota vaccine introduction. These findings highlight the importance of implementing preventive measures, such as vaccination, to reduce the burden of rotavirus infection in this population. The identified genotypes provide valuable insights for vaccine development and targeted interventions. This study contributes to the evidence base for public health interventions and strategies to reduce the impact of rotavirus infection in children under five in Ethiopia. Despite the rollout of the Rota vaccination in Ethiopia, rotavirus heterogeneity is still high, and thus, enhancing vaccination and immunization is essential. Abstract Background Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in high deaths annually, mainly in low-income countries, including Ethiopia, and need special attention. This system review and meta-analysis aimed to comprehensively explore the positive proportion of rotavirus at pre- and post-vaccine introduction periods and genotype distribution in children under five with diarrhea in Ethiopia. Methods The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Database sources included PubMed, Scopus, EMBASE, and Epistemonikos, focusing on studies published before November 30, 2023. The search targeted rotavirus infection and genotype distribution in Ethiopia before and after the introduction of the Rota vaccine. Data was managed using EndNote 2020 software and stored in an Excel 2010 sheet. A random-effects model determined the pooled estimate of the rotavirus infection rate at 95% confidence intervals. The Q-and I² statistics were used to assess the study heterogeneity, and a funnel plot (Egger test) was used to determine the possibility of publication bias. Results The analysis included data from nine studies conducted in different regions of Ethiopia. The overall prevalence of rotavirus infection was significant, with a prevalence rate of approximately 22.63% (1362/6039). The most common genotypes identified before the Rota vacation introduction were G1, G2, G3, G12, P [4], P [6], P [8], P [9], and P [10]. Meanwhile, G3 and P [8] genotypes were particularly prevalent after the Rota vaccine introduction. These findings highlight the importance of implementing preventive measures, such as vaccination, to reduce the burden of rotavirus infection in this population. The identified genotypes provide valuable insights for vaccine development and targeted interventions. Conclusion This study contributes to the evidence base for public health interventions and strategies to reduce the impact of rotavirus infection in children under five in Ethiopia. Despite the rollout of the Rota vaccination in Ethiopia, rotavirus heterogeneity is still high, and thus, enhancing vaccination and immunization is essential. BackgroundRotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in high deaths annually, mainly in low-income countries, including Ethiopia, and need special attention. This system review and meta-analysis aimed to comprehensively explore the positive proportion of rotavirus at pre- and post-vaccine introduction periods and genotype distribution in children under five with diarrhea in Ethiopia.MethodsThe review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Database sources included PubMed, Scopus, EMBASE, and Epistemonikos, focusing on studies published before November 30, 2023. The search targeted rotavirus infection and genotype distribution in Ethiopia before and after the introduction of the Rota vaccine. Data was managed using EndNote 2020 software and stored in an Excel 2010 sheet. A random-effects model determined the pooled estimate of the rotavirus infection rate at 95% confidence intervals. The Q-and I² statistics were used to assess the study heterogeneity, and a funnel plot (Egger test) was used to determine the possibility of publication bias.ResultsThe analysis included data from nine studies conducted in different regions of Ethiopia. The overall prevalence of rotavirus infection was significant, with a prevalence rate of approximately 22.63% (1362/6039). The most common genotypes identified before the Rota vacation introduction were G1, G2, G3, G12, P [4], P [6], P [8], P [9], and P [10]. Meanwhile, G3 and P [8] genotypes were particularly prevalent after the Rota vaccine introduction. These findings highlight the importance of implementing preventive measures, such as vaccination, to reduce the burden of rotavirus infection in this population. The identified genotypes provide valuable insights for vaccine development and targeted interventions.ConclusionThis study contributes to the evidence base for public health interventions and strategies to reduce the impact of rotavirus infection in children under five in Ethiopia. Despite the rollout of the Rota vaccination in Ethiopia, rotavirus heterogeneity is still high, and thus, enhancing vaccination and immunization is essential. Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in high deaths annually, mainly in low-income countries, including Ethiopia, and need special attention. This system review and meta-analysis aimed to comprehensively explore the positive proportion of rotavirus at pre- and post-vaccine introduction periods and genotype distribution in children under five with diarrhea in Ethiopia.BACKGROUNDRotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in high deaths annually, mainly in low-income countries, including Ethiopia, and need special attention. This system review and meta-analysis aimed to comprehensively explore the positive proportion of rotavirus at pre- and post-vaccine introduction periods and genotype distribution in children under five with diarrhea in Ethiopia.The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Database sources included PubMed, Scopus, EMBASE, and Epistemonikos, focusing on studies published before November 30, 2023. The search targeted rotavirus infection and genotype distribution in Ethiopia before and after the introduction of the Rota vaccine. Data was managed using EndNote 2020 software and stored in an Excel 2010 sheet. A random-effects model determined the pooled estimate of the rotavirus infection rate at 95% confidence intervals. The Q-and I² statistics were used to assess the study heterogeneity, and a funnel plot (Egger test) was used to determine the possibility of publication bias.METHODSThe review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Database sources included PubMed, Scopus, EMBASE, and Epistemonikos, focusing on studies published before November 30, 2023. The search targeted rotavirus infection and genotype distribution in Ethiopia before and after the introduction of the Rota vaccine. Data was managed using EndNote 2020 software and stored in an Excel 2010 sheet. A random-effects model determined the pooled estimate of the rotavirus infection rate at 95% confidence intervals. The Q-and I² statistics were used to assess the study heterogeneity, and a funnel plot (Egger test) was used to determine the possibility of publication bias.The analysis included data from nine studies conducted in different regions of Ethiopia. The overall prevalence of rotavirus infection was significant, with a prevalence rate of approximately 22.63% (1362/6039). The most common genotypes identified before the Rota vacation introduction were G1, G2, G3, G12, P [4], P [6], P [8], P [9], and P [10]. Meanwhile, G3 and P [8] genotypes were particularly prevalent after the Rota vaccine introduction. These findings highlight the importance of implementing preventive measures, such as vaccination, to reduce the burden of rotavirus infection in this population. The identified genotypes provide valuable insights for vaccine development and targeted interventions.RESULTSThe analysis included data from nine studies conducted in different regions of Ethiopia. The overall prevalence of rotavirus infection was significant, with a prevalence rate of approximately 22.63% (1362/6039). The most common genotypes identified before the Rota vacation introduction were G1, G2, G3, G12, P [4], P [6], P [8], P [9], and P [10]. Meanwhile, G3 and P [8] genotypes were particularly prevalent after the Rota vaccine introduction. These findings highlight the importance of implementing preventive measures, such as vaccination, to reduce the burden of rotavirus infection in this population. The identified genotypes provide valuable insights for vaccine development and targeted interventions.This study contributes to the evidence base for public health interventions and strategies to reduce the impact of rotavirus infection in children under five in Ethiopia. Despite the rollout of the Rota vaccination in Ethiopia, rotavirus heterogeneity is still high, and thus, enhancing vaccination and immunization is essential.CONCLUSIONThis study contributes to the evidence base for public health interventions and strategies to reduce the impact of rotavirus infection in children under five in Ethiopia. Despite the rollout of the Rota vaccination in Ethiopia, rotavirus heterogeneity is still high, and thus, enhancing vaccination and immunization is essential. Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction of vaccinations for rotavirus over a decade ago, rotavirus infections still result in high deaths annually, mainly in low-income countries, including Ethiopia, and need special attention. This system review and meta-analysis aimed to comprehensively explore the positive proportion of rotavirus at pre- and post-vaccine introduction periods and genotype distribution in children under five with diarrhea in Ethiopia. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Database sources included PubMed, Scopus, EMBASE, and Epistemonikos, focusing on studies published before November 30, 2023. The search targeted rotavirus infection and genotype distribution in Ethiopia before and after the introduction of the Rota vaccine. Data was managed using EndNote 2020 software and stored in an Excel 2010 sheet. A random-effects model determined the pooled estimate of the rotavirus infection rate at 95% confidence intervals. The Q-and I² statistics were used to assess the study heterogeneity, and a funnel plot (Egger test) was used to determine the possibility of publication bias. The analysis included data from nine studies conducted in different regions of Ethiopia. The overall prevalence of rotavirus infection was significant, with a prevalence rate of approximately 22.63% (1362/6039). The most common genotypes identified before the Rota vacation introduction were G1, G2, G3, G12, P [4], P [6], P [8], P [9], and P [10]. Meanwhile, G3 and P [8] genotypes were particularly prevalent after the Rota vaccine introduction. These findings highlight the importance of implementing preventive measures, such as vaccination, to reduce the burden of rotavirus infection in this population. The identified genotypes provide valuable insights for vaccine development and targeted interventions. This study contributes to the evidence base for public health interventions and strategies to reduce the impact of rotavirus infection in children under five in Ethiopia. Despite the rollout of the Rota vaccination in Ethiopia, rotavirus heterogeneity is still high, and thus, enhancing vaccination and immunization is essential. |
| ArticleNumber | 836 |
| Audience | Academic |
| Author | Tosisa, Wagi Eshetu, Daniel Irenso, Asnake Ararsa Mulu, Andargachew Hundie, Gadissa Bedada Regassa, Belay Tafa |
| Author_xml | – sequence: 1 givenname: Wagi surname: Tosisa fullname: Tosisa, Wagi – sequence: 2 givenname: Belay Tafa surname: Regassa fullname: Regassa, Belay Tafa – sequence: 3 givenname: Daniel surname: Eshetu fullname: Eshetu, Daniel – sequence: 4 givenname: Asnake Ararsa surname: Irenso fullname: Irenso, Asnake Ararsa – sequence: 5 givenname: Andargachew surname: Mulu fullname: Mulu, Andargachew – sequence: 6 givenname: Gadissa Bedada surname: Hundie fullname: Hundie, Gadissa Bedada |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39152402$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks1u1DAUhSNURH_gBVigSGxgkWI7Thyzq6oCI1WqVH621o1zPXWViYPtDMwb8Ng4My0wFUIoCyfWd07sc89xdjC4AbPsOSWnlDb1m0BZI2RBGC-IFBUvxKPsiHJBC1aW_OCP98PsOIRbQqhomHySHZaSVowTdpT9uHYR1tZPIbeDQR2tG0IOQ5fHG7Q-X-Lg4mbEvLMhettOM5CPHostNLoQizVobQdMBtG7btp6pI_8It5YN1p4m0MeNiHiyurc49rit614hREKGKDfBBueZo8N9AGf3a0n2ed3F5_OPxSXV-8X52eXha5EHYuWysZoYsqStsZAUzGDaCRiy0UtmtIQDaIkCaHYtkh0hQ0vQTBkUNPalCfZYufbObhVo7cr8BvlwKrthvNLBT5a3aPSshIyRWxaqHknWlmnQBmDpuYVa7hIXq92XqN3XycMUa1s0Nj3MKCbgiqJ5IRzLsuEvnyA3rrJp7sniqYJCikI_U0tIf0_DcRFD3o2VWcNaViaG5WJOv0LlZ5uTjh1xNi0vyd4vSdITMTvcQlTCGrx8fr_2asv--yLu0tN7Qq7X2ne1ysBzQ7Q3oXg0ShtI8z9SCe2vaJEzU1WuyarlIPaNlnN2bIH0nv3f4h-AkXw86s |
| CitedBy_id | crossref_primary_10_3390_v17030410 |
| Cites_doi | 10.1016/S1473-3099(13)70324-4 10.1097/INF.0000000000003921 10.1056/NEJMoa052434 10.1080/14760584.2020.1775079 10.1080/21645515.2021.1883387 10.1007/s00431-010-1242-3 10.1055/s-0042-1745836 10.1186/1743-422X-10-287 10.1093/cid/cit164 10.1086/653557 10.1186/s12879-022-07825-1 10.2223/1150 10.1586/erv.10.17 10.5772/intechopen.109466 10.1038/s41541-023-00632-y 10.1016/j.vaccine.2021.03.021 10.2217/fmb.09.96 10.4103/NJM.NJM_114_21 10.1016/j.ijsu.2021.105906 10.1016/j.jgar.2014.02.004 |
| ContentType | Journal Article |
| Copyright | 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QL 7T2 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU COVID DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
| DOI | 10.1186/s12879-024-09754-7 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1471-2334 |
| EndPage | 13 |
| ExternalDocumentID | oai_doaj_org_article_c9579287fba64d7b9614722a86452847 A808239119 39152402 10_1186_s12879_024_09754_7 |
| Genre | Meta-Analysis Systematic Review Journal Article |
| GeographicLocations | Ethiopia |
| GeographicLocations_xml | – name: Ethiopia |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PMFND 3V. 7QL 7T2 7U9 7XB 8FK AZQEC C1K COVID DWQXO H94 K9. M7N PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c576t-b198fc0f331bffa852feef9eeb476783f0ca730fc01ebbe0c5e843a72e2a616f3 |
| IEDL.DBID | 7X7 |
| ISSN | 1471-2334 |
| IngestDate | Wed Aug 27 01:28:52 EDT 2025 Fri Jul 11 15:08:42 EDT 2025 Fri Jul 25 20:04:09 EDT 2025 Tue Jun 17 22:03:48 EDT 2025 Tue Jun 10 21:04:27 EDT 2025 Fri Jun 27 06:03:10 EDT 2025 Fri Jun 27 05:58:38 EDT 2025 Mon Jul 21 05:50:20 EDT 2025 Tue Jul 01 03:10:50 EDT 2025 Thu Apr 24 23:11:51 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Post-vaccine Pre-vaccine Ethiopia Genotypes Rotavirus infection |
| Language | English |
| License | 2024. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c576t-b198fc0f331bffa852feef9eeb476783f0ca730fc01ebbe0c5e843a72e2a616f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.proquest.com/docview/3102479701?pq-origsite=%requestingapplication% |
| PMID | 39152402 |
| PQID | 3102479701 |
| PQPubID | 42582 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c9579287fba64d7b9614722a86452847 proquest_miscellaneous_3094044493 proquest_journals_3102479701 gale_infotracmisc_A808239119 gale_infotracacademiconefile_A808239119 gale_incontextgauss_ISR_A808239119 gale_incontextgauss_IOV_A808239119 pubmed_primary_39152402 crossref_citationtrail_10_1186_s12879_024_09754_7 crossref_primary_10_1186_s12879_024_09754_7 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-16 |
| PublicationDateYYYYMMDD | 2024-08-16 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-16 day: 16 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC infectious diseases |
| PublicationTitleAlternate | BMC Infect Dis |
| PublicationYear | 2024 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | N Field (9754_CR15) 2014; 14 GM Ruiz-Palacios (9754_CR24) 2006; 354 G Stintzing (9754_CR9) 1981; 59 MJ Page (9754_CR14) 2021; 88 KB Ali (9754_CR1) 2022; 31 K Nirmal (9754_CR5) 2023 9754_CR16 DEF Slotboom (9754_CR3) 2023; 42 DG Miretu (9754_CR12) 2021; 17 9754_CR13 JM Mwenda (9754_CR20) 2010; 202 BD Hallowell (9754_CR7) 2020; 19 T Vesikari (9754_CR23) 2010; 169 KA Atalell (9754_CR10) 2022; 22 I Mandomando (9754_CR11) 2021; 39 DC Payne (9754_CR22) 2013; 57 MK Basaran (9754_CR4) 2022; 17 9754_CR6 J Matthijnssens (9754_CR17) 2009; 4 F Moges (9754_CR8) 2014; 2 CC Enweronu-Laryea (9754_CR21) 2013; 10 JE Tate (9754_CR19) 2010; 9 PS Costa (9754_CR18) 2004; 80 ANM Kraay (9754_CR2) 2023; 8 |
| References_xml | – volume: 14 start-page: 341 issue: 4 year: 2014 ident: 9754_CR15 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(13)70324-4 – volume: 42 start-page: 533 issue: 7 year: 2023 ident: 9754_CR3 publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0000000000003921 – volume: 354 start-page: 11 issue: 1 year: 2006 ident: 9754_CR24 publication-title: N Engl J Med doi: 10.1056/NEJMoa052434 – volume: 19 start-page: 529 issue: 6 year: 2020 ident: 9754_CR7 publication-title: Expert Rev Vaccines doi: 10.1080/14760584.2020.1775079 – volume: 17 start-page: 2427 issue: 8 year: 2021 ident: 9754_CR12 publication-title: Hum Vaccines Immunotherapeutics doi: 10.1080/21645515.2021.1883387 – ident: 9754_CR16 – volume: 169 start-page: 1379 year: 2010 ident: 9754_CR23 publication-title: Eur J Pediatrics doi: 10.1007/s00431-010-1242-3 – volume: 17 start-page: 137 issue: 03 year: 2022 ident: 9754_CR4 publication-title: J Pediatr Infect Dis doi: 10.1055/s-0042-1745836 – volume: 10 start-page: 1 year: 2013 ident: 9754_CR21 publication-title: Virol J doi: 10.1186/1743-422X-10-287 – volume: 57 start-page: 13 issue: 1 year: 2013 ident: 9754_CR22 publication-title: Clin Infect Dis doi: 10.1093/cid/cit164 – volume: 59 start-page: 67 issue: 1 year: 1981 ident: 9754_CR9 publication-title: Bull World Health Organ – volume: 202 start-page: S5 issue: Supplement1 year: 2010 ident: 9754_CR20 publication-title: J Infect Dis doi: 10.1086/653557 – volume: 22 start-page: 830 issue: 1 year: 2022 ident: 9754_CR10 publication-title: BMC Infect Dis doi: 10.1186/s12879-022-07825-1 – volume: 80 start-page: 119 year: 2004 ident: 9754_CR18 publication-title: Jornal De Pediatria doi: 10.2223/1150 – volume: 9 start-page: 395 issue: 4 year: 2010 ident: 9754_CR19 publication-title: Expert Rev Vaccines doi: 10.1586/erv.10.17 – ident: 9754_CR6 – volume-title: Rotaviral diseases and their implications year: 2023 ident: 9754_CR5 doi: 10.5772/intechopen.109466 – volume: 8 start-page: 32 issue: 1 year: 2023 ident: 9754_CR2 publication-title: npj Vaccines doi: 10.1038/s41541-023-00632-y – volume: 39 start-page: 3111 issue: 23 year: 2021 ident: 9754_CR11 publication-title: Vaccine doi: 10.1016/j.vaccine.2021.03.021 – volume: 4 start-page: 1303 issue: 10 year: 2009 ident: 9754_CR17 publication-title: Future Microbiol doi: 10.2217/fmb.09.96 – volume: 31 start-page: 35 issue: 1 year: 2022 ident: 9754_CR1 publication-title: Niger J Med doi: 10.4103/NJM.NJM_114_21 – ident: 9754_CR13 – volume: 88 start-page: 105906 year: 2021 ident: 9754_CR14 publication-title: Int J Surg doi: 10.1016/j.ijsu.2021.105906 – volume: 2 start-page: 148 issue: 3 year: 2014 ident: 9754_CR8 publication-title: J Global Antimicrob Resist doi: 10.1016/j.jgar.2014.02.004 |
| SSID | ssj0017829 |
| Score | 2.4056206 |
| SecondaryResourceType | review_article |
| Snippet | Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global introduction... Background Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global... BackgroundRotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the global... Abstract Background Rotavirus infections are a significant cause of severe diarrhea and related illness and death in children under five worldwide. Despite the... |
| SourceID | doaj proquest gale pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source |
| StartPage | 836 |
| SubjectTerms | Age groups Analysis BCG BCG vaccines Breastfeeding & lactation Child, Preschool Children Childrens health Confidence intervals Developing countries Diarrhea Diarrhea - epidemiology Diarrhea - prevention & control Diarrhea - virology Distribution Epidemiology Ethiopia Ethiopia - epidemiology Fatalities Gastroenteritis Genetic aspects Genotype Genotype & phenotype Genotypes Health promotion Heterogeneity Humans Immunization Inclusion Infant Infection Infections Infectious diseases LDCs Low income areas Medical research Medical Subject Headings-MeSH Medicine, Experimental Meta-analysis Parasites Physiological aspects Population studies Post-vaccine Pre-vaccine Prevalence Prevalence studies (Epidemiology) Public health Risk factors Rotavirus Rotavirus - classification Rotavirus - genetics Rotavirus - immunology Rotavirus - isolation & purification Rotavirus infection Rotavirus infections Rotavirus Infections - epidemiology Rotavirus Infections - prevention & control Rotavirus Infections - virology Rotavirus Vaccines - administration & dosage Rotaviruses Software Statistical analysis Statistical tests Vaccination Vaccination - statistics & numerical data Vaccine development Vaccines Viral genetics Viruses |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pi9UwEA6yB_Ei_vbpKlEEDxK2bdKk8baKyyqosLqyt5CkyfJA28e2b_8G_2xn0vRhFfXi9fVL6UsmM5PMzDeEPAMfRNoi1Kz2Cq9uLGcai32qquQy8BZDWZht8UEen4p3Z_XZT62-MCdsogeeJu7AYxwJ3ProrBStchrsiaoq22BEDlQral-wefNhKscPwO7puUSmkQcDaGGlGdgjVmhVC6YWZiix9f-uk3_xNJPFObpBrmdXkR5On3iTXAndLXL1fQ6G3ybfT_rRXq4vtgOdU6q6gdqupen2nyL9Kt6w0hbJcXNfK4ppHwm06YeRXVqPL4MXjBP1K0LWHcU0-H6zti-ppRPZ89rTqcwlDf4WRstsJjS5Q06P3nx-fcxyYwXm4XgxMlfqJvoicl66GG1TVzGEqENwQoHx4rHwFnY-QMrgXCh8HRrBrapCZWUpI79L9rq-C_cJLaUNSmE1q3XClbyx4FO0spXcwflUqBUp53k2PrOOY_OLryadPhppprUxsDYmrY2BMS92YzYT58Zf0a9w-XZI5MtOP4AUmSxF5l9StCJPcfENMmJ0mHJzbrfDYN5-_GIOGwxGgk3QfwJ9OlmAnmdQ7OGPepvLHGC6kGlrgdxfIGFf--XjWRBN1iuDAWe8EkqrolyRJ7vHOBJz5brQbwGDlIhCCM1X5N4kwLvJwXYAGE978D8m7SG5VqUt1bBS7pO98WIbHoGLNrrHaTf-ANT4M_I priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1taxQxEA61gggiWt-uVoki-EFiN5tssiuIVLFUoQrVk34LyW62HNTd6-1e0X_gz3Ymmz05rf16-0zuLsnsTDIzzxDyDHwQZROfsazUeHVjBSuw2CdNuVBeVBjKwmyLT-pgKj8eZ8cbZGx3FCewu_Boh_2kpovTlz_Ofr4BhX8dFD5Xux28Y3XBwNqwpNCZZPoKuQqWSaOiHso_UQWwhsVYOHOh3JpxChz-_76p__I_gx3av0VuRgeS7g0rfpts-GaLXDuMIfItcmO4iKNDfdEd8uuo7e35bLHs6Jh41XTUNhUNMQKKJK14D0srpNCN3a8oJocE0LztenZuSxwcBugHgliEzBqKyfLtfGZfUUsHSmj44qEYJgh_971lNtKe3CXT_fdf3x2w2H6BlXAI6ZnjRV6XSS0Ed3Vt8yytva8L753UYOJEnZQW3g8A4d45n5SZz6WwOvWpVVzV4h7ZbNrGPyCUK-u1xppX66TjIrfgeVSqUsLBKVbqCeHjvJsycpNji4xTE84ouTLDWhlYKxPWyoDMi5XMfGDmuBT9FpdzhURW7fBBuzgxUUlNiTFLkKydVbLSrgDfRaepzTH6G37mU9wMBnkzGkzMObHLrjMfPn8zezmGLMFyFP8DfTlaAz2PoLqFP1raWAwB04V8XGvInTUkaH-5_njcmGZUHgMueyp1oRM-IU9Wj1ESM-oa3y4Bg8SJUspCTMj9YUOvJgebBmDUbfvywR-S62lQnpxxtUM2-8XSPwIXrXePg979BlY6NS0 priority: 102 providerName: Scholars Portal |
| Title | Rotavirus infections and their genotype distribution pre- and post-vaccine introduction in Ethiopia: a systemic review and meta-analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39152402 https://www.proquest.com/docview/3102479701 https://www.proquest.com/docview/3094044493 https://doaj.org/article/c9579287fba64d7b9614722a86452847 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgkxASQjBuhVEZhMQDshbHjp3wgtZp00DaQIWhihfLcZypEiSlSfcb-Nmc47hFBbGXPDSf3daX4-Nz-Q4hr0AHUTbxGcucRtONFazAZJ805UJ5UaErC6MtztXphfwwy2bR4NbFsMq1TAyCumod2sgPQA1JpS50wt8tfjKsGoXe1VhC4ybZReoyDOnSs82Fi8PpV6wTZXJ10IEs1gWDflhS6EwyvXUYBc7-fyXzX_pmOHdO7pG7UWGkh8MM3yc3fLNHbp1Fl_geuTMY3uiQT_SA_Jq2vb2aL1cdXQdaNR21TUWDT4AiKSvaXWmFlLmx2hXFYJAAWrRdz66sw86hg34ghEXIvKEYHN8u5vYttXSggIYvHpJfQuMfvrfMRpqTh-Ti5PjL0SmL5RaYg0tHz0pe5LVLaiF4Wdc2z9La-7rwvpQajjRRJ86CPAAI92XpE5f5XAqrU59axVUtHpGdpm38E0K5sl5rzHG1pSy5yC1oGpWqlCjh1ir1iPD1uBsXucixJMZ3E-4kuTLDXBmYKxPmykCbN5s2i4GJ41r0BKdzg0QW7fBBu7w0cVMahz5KaFmXVslKlwXoKjpNbY7e3vAzX-JiMMiT0WAgzqVddZ15__GrOczRRQknRfE_0OfpFuh1BNUt_FFnY_IDDBfyb20h97eQsNvd9uv1wjRR2nTmz94YkReb19gSI-ga364Ag0SJUspCjMjjYUFvBgeLBKCX7en1nT8jt9OweXLG1T7Z6Zcr_xxUsr4ch30Hz_yIj8nu5Pj803QczBvwPJM5PKeTb78Byqk3Lw |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELVKkaASQlAuXShgEIiHympiJ3aChFC5VLv0glRatG_GTpxqJUiWTbaIP-Br-EZmnGTRguhbXzfH3sQznhl7boQ8BRtEmsDFLM4UXt0YwVJM9uE8FNKJHF1ZGG1xKIcn0ftxPF4hv_pcGAyr7GWiF9R5leEd-TaYITxSqQrCV9NvDLtGoXe1b6HRssWe-_Edjmz1y9FboO8zznffHb8Zsq6rAMvAtm6YhWN2kQWFEKEtCpPEvHCuSJ2zkQLJLYogM8D2AAmdtS7IYpdEwijuuJGhLATMe4lcBsUb4I5S48UBLwRtm_aJOYncrkH2q5TBe7MgVXHE1JLy8z0C_tUEf9m3Xs_t3iDXOwOV7rQcdZOsuHKdXDnoXPDr5Fp70Ufb_KVb5OdR1ZizyWxe0z6wq6ypKXPqfRAUi8DiPS_NsURv112LYvCJB02rumFnJsPJYYKmLUCLkElJMRi_mk7MC2poW3Ia_rhNtvGDv7rGMNOVVblNTi6EEHfIalmVboPQUBqnFObUGhvZUCQGLJtc5lJYOCVHakDCft111tU-xxYcX7Q_AyVSt7TSQCvtaaVhzNZizLSt_HEu-jWSc4HEqt3-h2p2qjshoDP0icLIwhoZ5cqmYBspzk2C3mX_mk-QGTTW5Sgx8OfUzOtajz580jsJukRBM6X_A308WgI970BFBR-amS7ZApYL630tITeXkCBdsuXHPWPqTrrV-s9eHJDHi8c4EiP2SlfNAYOFGaMoSsWA3G0ZerE42JQAvXr3zp_8Ebk6PD7Y1_ujw737ZI37jZSwUG6S1WY2dw_AHGzsQ78HKfl80Zv-N7UXcNE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rotavirus+infections+and+their+genotype+distribution+pre-+and+post-vaccine+introduction+in+Ethiopia%3A+a+systemic+review+and+meta-analysis&rft.jtitle=BMC+infectious+diseases&rft.au=Tosisa%2C+Wagi&rft.au=Regassa%2C+Belay+Tafa&rft.au=Eshetu%2C+Daniel&rft.au=Irenso%2C+Asnake+Ararsa&rft.date=2024-08-16&rft.pub=BioMed+Central&rft.eissn=1471-2334&rft.volume=24&rft.spage=1&rft_id=info:doi/10.1186%2Fs12879-024-09754-7 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |